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Abstract
The G-protein-coupled receptors Lgr4/5/6 are Wnt signalling mediators, but their functions in 
squamous carcinomas (SCCs) are unclear. Using lineage tracing in Lgr5-EGFP-CreERT2- and 
Lgr6-EGFP-CreERT2- Rosa26/Tomato reporter mice, we demonstrate that Lgr6, but not Lgr5, 
acts as an epithelial stem cell marker in vivo in SCCs. We identify, by single molecule in situ 
hybridisation and cell sorting, rare Lgr6-positive cells in immortalised keratinocytes, and show 
that their frequency increases in advanced SCCs. Lgr6 expression is enriched in cells with stem 
cell characteristics, and Lgr6 downregulation in vivo causes increased epidermal proliferation, 
with expanded lineage tracing from Lgr6+ epidermal stem cells. Surprisingly, Lgr6 germline 
knockout mice are predisposed to SCC development, by a mechanism that includes compensatory 
upregulation of Lgr5. These data provide a model for human patients with germline loss of 
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function mutations in WNT pathway genes RSPO1 or LGR4, who show increased susceptibility to 
squamous tumour development.
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Lgr6; Lgr5; skin; lineage tracing; stem cells
Introduction
The mouse skin hair follicle (HF) comprises several distinct stem cell populations1–3. 
Lrig13,4 defines a cell population in the HF junctional zone that serves to maintain the HF 
infundibulum5–7, while quiescent Krt15-positive stem cells in the bulge region act as a 
reserve stem cell pool that becomes activated in response to stress8. Lgr4-6 are expressed in 
stem cells in many tissues, including the small intestine9, breast10, ovary11,12 and 
haematopoietic system13. In the skin, Lgr5 has been genetically linked to a network of genes 
that are expressed specifically in the HF14,15, while Lgr6 is expressed in the isthmus region, 
sebaceous gland and interfollicular epidermis1617.
The Lgr4-6 receptors bind R-spondins (Rspo1-4) to enhance Wnt/β-catenin signalling18–21. 
Wnt signalling is known to be activated in the hair germ and HF bulge during the transition 
from telogen to anagen phase, and is critical for the formation of new follicles22–25. 
However, several reports have also indicated a negative role for Lgr5 in Wnt signalling, 
including in human colorectal cancers26,27. Moreover, loss-of-function mutations in human 
RSPO128 and LGR429 increase susceptibility to skin squamous carcinoma development, and 
LGR6 has been implicated both as a potential tumour suppressor gene20, and a breast cancer 
germline susceptibility gene30. Thus, the exact roles of Lgr4-6 in Wnt signalling and 
tumourigenesis appear to vary depending on the specific Lgr4-6 and Rspo1-4 family 
members that are expressed and interact in a given cellular context27.
The relationships between normal tissue stem cells and “cancer stem cells” (CSCs, also 
known as “tumour initiating cells”) are controversial and unresolved31–35. Lgr5 has been 
reported to be a marker of both normal stem cells and CSCs in intestinal adenoma36, and in 
gastric cancer37 but it remains unclear whether members of this gene family are expressed, 
and in particular play a functional role, in CSCs in other tumour types including cutaneous 
SCC.
Here, we identify a specific role for Lgr6 as a cutaneous CSC marker. Expression of Lgr6, 
but not Lgr5, increases during tumour progression and metastases, while lineage tracing in 
established tumours shows that only the progeny of Lgr6-positive cells form significant 
epithelial colonies within SCCs. Nevertheless, germline deletion of Lgr6 predisposes mice 
to development of SCCs. These data underline the parallels between this mouse model and 
human patients with germline loss of genes within this pathway, including RSPO1 and 
LGR4, who also have increased propensity for SCC development.
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Results
Lgr6 is a stem cell marker in squamous carcinoma
Mouse skin SCCs can be initiated with a single dose of Dimethyl-benzanthracene (DMBA) 
and promoted by repeated treatment with 12-O-tetradecanoyl-phorbol-13-acetate (TPA)38. 
Tumours from this model have common activating mutations in Ras oncogenes, and 
progress through benign and malignant stages, ultimately metastasising to cause the death of 
the host animals39. While the existence of stem cells within tumours in this model has been 
documented40, the relationship between these CSCs, and markers of normal stem cells, is 
unknown. We first analysed published gene expression data from samples of normal skin, 
papillomas, primary carcinomas and matched metastatic tumours from an interspecific 
FVBBX backcross population39. While Lgr6 expression continues to rise during 
progression, Lgr5 expression shows a decrease, suggesting that Lgr5 may not be required for 
tumour maintenance (Figure 1a).
We investigated the localised expression of Lgr5 and Lgr6 in SCCs from mice carrying an 
EGFP reporter gene under the control of the Lgr5 or Lgr6 promoters (Lgr5-EGFP-CreERT2 
and Lgr6-EGFP-CreERT2 mice15,16). Staining of tumours using antibodies against GFP 
(Lgr6, green) or Keratin 14 (Krt14, red) (Figure 1b–e and Supp. Fig. 1) showed that Lgr6 
(Fig. 1e), but not Lgr5 (Fig. 1c), is clearly expressed in distinct colonies of cells distributed 
through the SCCs. Patterns of co-staining for GFP and Krt14 suggest that while the vast 
majority of Lgr6-positive cells are in the epithelial compartment, the average expression 
levels of Krt14 in these cells is relatively low compared to the adjacent more differentiated 
cells (Supp. Fig. 1i, insert). These data are thus compatible with the hypothesis that Lgr6 
may act as a stem cell marker in squamous carcinomas, whereas Lgr5 does not.
Lgr5+ cells have been reported to be capable of acting as the cells-of-origin of intestinal and 
gastric adenoma41–43, cutaneous BCC44 and SCC45. Schepers et al.36 exploited the Lgr5-
EGFP-IRES-CreERT2+/− mouse to activate Wnt signalling in the Lgr5-positive crypt stem 
cells, and showed that the resulting adenomas continued to express Lgr5. We asked whether 
induction of Ras mutations within Lgr5-positive stem cells in the hair follicle gives rise to 
SCCs that continue to express Lgr5, or if it is dispensable for tumour maintenance. We 
crossed Lgr5-EGFP-IRES-CreERT2+/− or Lgr6-EGFP-IRES-CreERT2+/− mice with 
KrasLSL-G12D mice carrying a floxed mutant Kras allele46. Activation of oncogenic Kras 
with topical 4-hydroxytamoxifen (4OHT) in Lgr5-positive stem cells resulted in some 
limited sebaceous gland hyperplasia (Supp. Fig. 2a), but when the mice were further 
challenged with a back wound stimulus, papillomas readily arose within 4 weeks (Supp. Fig. 
2b). Similar observations were made after activation of Kras in the Lgr6-positive stem cell 
population (data not shown). These results are in agreement with the observations of 
Lapouge et al.47, but contrast with the findings of another study48 , possibly due to 
differences in the genetic background of the mice used in different laboratories.
Surgical removal of papillomas in Lgr5-EGFP-IRES-CreERT2+/−/KrasLSL-G12D/+ mice led 
to progression to aggressive spindle carcinomas (Supp. Fig. 2c). Lgr5 expression could be 
detected in the outer root sheath (ORS) of HFs in normal skin from Lgr5-EGFP-IRES- 
CreERT2+/−/KrasLSL-G12D/+ mice (Supp. Fig. 2d), or in HFs close to the carcinomas, but not 
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in the epithelial carcinoma cells (Supp. Fig. 2e). TaqMan and immunofluorescence analyses 
of 3 independently derived cell lines derived from these spindle carcinomas showed an 
absence of Lgr5 expression (Supp. Fig. 2f, g) while Lgr4 and Lgr6 expression could readily 
be detected (Supp. Fig. 2f), We conclude that even tumours arising from Lgr5-positive cells 
in the HF fail to express Lgr5 during tumour progression, and that Lgr5 is not a positive 
driver of SCC growth.
Lineage tracing of Lgr6-positive stem cells in squamous tumours
CSCs can give rise to progeny within tumours that continue to fuel tumour development and 
progression40,49. We carried out lineage tracing within chemically induced skin tumours 
from Lgr6-EGFP-CreERT2 or Lgr5-EGFP-CreERT2 mice crossed with Rosa26-LSL-
Tomato reporter mice15,16 (hereafter Lgr6- or Lgr5-reporter mice). Early stage papillomas 
were induced in both double transgenic lines by standard DMBA treatment followed by 8 
weeks of tumour promotion using TPA (Supp. Fig. 3). At this stage, mice were treated with 
Tamoxifen and papillomas were harvested at different times (2 days, 3 weeks and 6 weeks) 
thereafter, to measure the extent of lineage tracing from either Lgr5- (Fig. 2a, c, e, g) or 
Lgr6-positive (Fig. 2b, d, f, g) stem cells. Imaging of fluorescent cell populations from 
papillomas 2 days after Tamoxifen treatment identified rare GFP/RFP positive cells in the 
epithelial compartment in Lgr6-reporter mice, but not in Lgr5-reporter mice. (Fig. 2a, b). 
The number of Tomato-positive traced cells increased at 3 weeks and 6 weeks, giving rise to 
distinct clones that showed evidence of migration from the initial Lgr6-positive cells (Fig 
2d,f). Some Tomato-positive traced cells in Lgr6-reporter mice were also observed in the 
dermis/stromal compartment (Supp. Fig. 4b, d), but these were only a minor population, the 
significance of which is unknown. In contrast, papillomas from Lgr5-reporter mice 
displayed very few Tomato-positive traced cells, even after 6 weeks, and the majority of 
these were found in the dermal compartment (Fig. 2e, g and Supp. Fig. 4a, c).
We also carried out lineage tracing from Lgr6-positive cells in primary carcinomas that arose 
between 24–30 weeks after tumour initiation. At 2 days (Fig. 3a,b), 2 weeks (Fig. 3c, d), and 
4 weeks (Fig. 3e, f) after tamoxifen treatment there was a significant increase in RFP-
positive cell numbers in comparison to papillomas. Lgr6-traced RFP-positive clones grew 
rapidly and occupied a significant proportion of the carcinoma 4 weeks after Cre activation 
(Fig. 4e,f). Again, no significant level of traced progeny cells was seen in the equivalent 
study of Lgr5-reporter mice (Supp. Fig. 5a–d). Interestingly, Driessens et al40 demonstrated 
that clonal populations arising in skin tumours from Krt14-CreER/RosaYFP mice treated 
with Tamoxifen showed a strong decrease in clone numbers over several weeks, but no such 
decrease was seen in clone number in our studies of serial biopsies of carcinomas from 
Lgr6-CreER/RosaRFP mice (Fig. 3). This suggests that Krt14 initially labels many transit 
amplifying cells with poor self-renewal capacity, whereas the Lgr6-positive population is 
already enriched in stem cells that are capable of long term self renewal.
The transcription factor Sox2 is expressed in papillomas and squamous carcinomas, and was 
reported to mark a stem cell population that is enriched in tumour-initiating cells50. We 
investigated possible overlap between Sox2-positive cells and Lgr6-positive cells in SCCs 
from the DMBA/TPA model by staining for Sox2 in tumours from Lgr6-EGFP-CreERT2 
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mice. The data in Supp. Fig 6 show that Sox2 is more widely expressed in a larger 
population of cells than is Lgr6, with minimal overlap between the cells expressing these 
two distinct markers.
Single cell analysis of Lgr5 and Lgr6 co-expression in normal keratinocytes and tumour 
cell lines
Analysis of gene expression at the single cell level is important in the context of CSCs, only 
a small and variable number of which may be present in solid tumours or tumour cell lines. 
We carried out gene expression microarray analysis of Lgr4, 5 and 6 levels in mouse cell 
lines representing various stages of chemically induced tumours51,52. Lgr5 was not 
expressed above background levels in any of these cell lines, while Lgr4 and Lgr6 were 
expressed at varying levels (Supp. Fig. 7). Taqman analysis (Fig. 4a), confirmed that Lgr5 
was not expressed above the limits of detection except in positive control back skin samples.
To address the possibility that Lgr5 may be expressed in rare single cells in keratinocyte 
cultures, we performed Lgr4-6 multiplex in situ hybridisation53. We also analysed a BCC 
cell line (Asz001)54, since Lgr5 has been reported to be expressed in BCC cells. Expression 
of Lgr5 was detected in the BCC cells by Taqman and qPCR analyses, albeit at very low 
levels (Fig. 4b arrow). In situ hybridisation analysis revealed that while Lgr4 was broadly 
expressed in Asz001 cells, Lgr5 and Lgr6 were more restricted in expression. Interestingly, 
all three family members were co-expressed in rare single cells (Fig. 4c and insets) at a 
frequency of about 0.75% (4 in 533 cells). This observation raises the intriguing possibility 
that these rare Lgr5, 6 and 4 triple-positive cells are CSCs in the BCC cell line, although 
further work would be needed to test this hypothesis.
In contrast to the BCC cell line, none of the SCC and keratinocyte cell lines showed 
significant Lgr5 expression (Fig. 4d, e, and Supp. Fig. 8). The SCC and keratinocyte cell 
lines showed different patterns of Lgr6 expression depending on degree of malignant 
transformation. In immortalised keratinocytes (C5N, Fig. 4d) and NK cells (Supp. Fig. 8), 
Lgr6 was expressed in single cells, together with Lgr4. A much larger population of cells 
expressed Lgr4 but not Lgr6, as also seen in all of the other cell lines tested (Fig. 4 and 
Supp. Fig. 8). Cell lines derived from tumours at more advanced stages (Fig. 4e: E4 cells, 
derived from a squamous lung metastasis) showed a high proportion of Lgr6-positive cells, 
in agreement with the observation of high expression levels in these cells by microarray 
analysis (Supp. Fig. 7). These data therefore demonstrate that, at the single cell level, there 
appears to be a hierarchy in expression patterns of the Lgr gene family. BCCs have distinct 
Lgr5-positive cells, some of which are triple-positive cells that express all three family 
members. Immortalised keratinocytes lack Lgr5, but have rare double-positive Lgr6 and 
Lgr4 cells, and these appear to increase in number in more advanced tumours.
Multiplex analysis of Lgr family gene expression using PCR-activated cell sorting (PACS)
To determine the levels of co-expression of Lgr4-6 at a more quantitative level, we used a 
novel PCR-activated Cell Sorting (PACS) technology55–57, (see Materials and Methods). 
With this method, we were able to identify and sort single cells by performing single-cell 
TaqMan RT-PCR reactions in >100,000 cells targeting Lgr4, 5 and 6 mRNA sequences. We 
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validated this approach using a subset of the cell lines that were analysed for Lgr gene 
expression by in situ hybridisation and microarrays. Figure 4f shows that almost 100% of 
the single NK (immortalised keratinocytes), E4 (metastatic squamous carcinoma cells), and 
ASZ001 (BCC) cells expressed Lgr4, in agreement with the results of in situ hybridisation. 
In contrast, about 1% of the BCC cells expressed Lgr5, however, there was no significant 
expression in NK cells (Fig. 4f). Interestingly, this extremely sensitive approach also 
identified a small population of E4 cells (around 0.4%) that expressed some Lgr5 (Fig. 4f) 
despite the fact that expression analysis by TaqMan (Fig. 4a), microarrays (Supp. Fig. 7), or 
in situ hybridisation (Fig. 4e) of the whole cell population did not detect any significant Lgr5 
transcripts. Lgr6 was expressed in over 90% of the E4 cells, and in about 10% of BCC cells, 
but only in about 1–2% of the NK cells, again in line with the in situ data (Supp. Fig. 8). We 
also analysed expression of the same genes in keratinocytes from normal mouse skin. Lgr4 
was quite widely expressed (20–30% of keratinocytes), in agreement with previous data on 
expression in mouse and human skin 16,58, while Lgr6, known to be expressed in the upper 
isthmus as well as the interfollicular epidermis16, was found in around 18% and Lgr5 in 
around 2% of single keratinocytes (Fig. 4f).
Further analysis of these data (Fig. 4g) confirmed the presence of Lgr4, 5 and 6 triple 
positive cells in vivo in normal keratinocytes. Around 1.5–2% of normal dorsal telogen skin 
keratinocytes expressed Lgr5 (Fig. 4f), and of these about 20% (0.3% of the total 
population) were triple positive (Fig. 4g). Comparable results were seen for the BCC cell 
line, where of the 1% of the total cell population that expressed Lgr5 (Fig. 4f) about 18% 
(0.18% of the total) were triple positive for all three genes (Fig. 4g). The concordance 
between in situ hybridisation and PACS sorting data for the cell lines indicates that in vivo 
there are specific subpopulations of Lgr5-expressing cells that also co-express the other 
family members. Whether these co-expression patterns are involved in cell fate decisions in 
normal skin homeostasis in vivo remains to be addressed. Interestingly, PACS analysis of 
primary squamous carcinoma also revealed the presence of a small population of triple 
positive cells (Supp. Fig. 8d, e). These cells however do not appear to be clonogenic in 
tumours, as the lineage tracing studies using the Lgr5-EGFP-CreERT2 allele failed to 
identify a significant population of traced epithelial tumour cells.
Lgr6 is enriched in keratinocyte cells with stem cell properties
To test the possibility that Lgr6-positive cells represent a stem cell subpopulation, we 
utilised the Aldefluor assay59–62 to isolate Aldefluor+ and Aldefluor− subpopulations from 
C5N and D3 cultures. Lgr6 expression was elevated in the Aldefluor+ fraction compared to 
the Aldefluor− fraction (Fig. 5a, b), and Aldefluor+ cells sorted from C5N cultures were 
capable of forming more and larger colonies in vitro than Aldefluor− cells (Fig. 5c). We 
conclude that Lgr6, and not Lgr5, acts as a marker of a stem-like cell population in 
squamous epidermal cells.
Lgr6 suppresses epidermal cell growth in vitro and in vivo
We next overexpressed Lgr6 in immortalised keratinocytes (NK cells), which have low 
endogenous levels of Lgr6 mRNA (Supp. Figs. 7, 8). Transfection of NK cells with an 
inducible Lgr6 expression construct (Fig. 5d) led to growth retardation after Doxycycline 
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treatment (Fig. 5e). To validate this growth suppressive effect of Lgr6 in epidermal cells, we 
knocked down Lgr6 in an SCC cell line (E4), which expresses relatively high endogenous 
levels of Lgr6 (Fig. 4e and Supp. Fig. 7). We transduced E4 cells with an inducible Lgr6 
shRNA construct, which, upon doxycycline administration, elicits efficient knockdown of 
Lgr6 without altering the levels of either Lgr4 or Lgr5 (Fig. 5f). Consistent with a growth 
suppressive role for Lgr6 in epidermal cells, doxycycline treatment of transduced E4 cells 
led to increased growth but had no effect on unmodified E4 cells (Fig. 5g).
Lgr6 knockdown in vivo expands lineage tracing in the skin
Lgr6 is a marker of infundibulum stem cells, but a possible functional role in control of 
homeostasis in vivo has not been investigated. Although the Lgr6−/− mouse is viable63, 
developmental adaptation to loss of expression could lead to compensatory mechanisms for 
controlling skin homeostasis in the adult mouse. We therefore generated Lgr6 KD mice, 
which possess an Lgr6 shRNA construct knocked into the Rosa26 locus that can be induced 
by doxycycline treatment (Fig. 6a). Adult Lgr6 KD mice were treated with doxycycline 
water for 10 days, leading to an approximately 60% reduction in Lgr6 expression levels in 
the back skin, while Lgr4 and Lgr5 levels were not significantly affected (Fig. 6b). 
Immunofluorescence analysis showed that doxycycline administration for this period 
resulted in an increase in proliferation in the epidermis of Lgr6 KD mice, as shown by BrdU 
labelling (Fig. 6c). These results therefore agree with the in vitro data shown in Fig. 5g.
We also tested the effect of Lgr6 downregulation in vivo on patterns of lineage tracing from 
Lgr6+ stem cells. We generated Lgr6 KD+/−/Lgr6-EGFP-IRES-CreERT2+//R26RLacZ+/− 
triple transgenic mice, and administered doxycycline to 8-week- old triple transgenic 
animals and controls for 10 days, followed by activation of Cre recombinase by topical 
4OHT treatment. Skin samples were collected 7 days thereafter, and X-Gal analysis revealed 
a striking increase in the number of LacZ-positive cells in the epidermis (Fig. 6d,e,f) in 
doxycycline-treated mice. This expanded epidermal lineage tracing was accompanied by an 
increase in the clone size (Fig. 6g), suggesting that Lgr6 downregulation led to increased 
proliferation within the Lgr6 progeny compartment in the epidermis, in line with our 
observations above (Fig. 6c). It is not possible at this stage to determine whether the increase 
in traced cells in the epidermis is due to migration from the Lgr6-positive cells in the 
isthmus region, or to independent proliferation of Lgr6-positive cells that have been 
identified within the epidermis17. Interestingly, we also saw evidence for Lgr6 lineage 
tracing within the dermis, which was particularly elevated in the doxycycline-treated animals 
(Fig. 6d, lower panel) and has not been previously reported. Control skin from non-4OHT 
treated adult Lgr6-EGFP-IRES-CreERT2+/−/R26RLacZ+/− mice showed no staining in 
either the HFs or the IFE, indicating the non- leakiness of the Lgr6-EGFP-IRES-CreERT2+/− 
promoter construct (Supp. Fig. 9).
Lgr6 activates Wnt signalling but is a germline tumour suppressor gene
Lgr5 has been reported to be overexpressed in hepatocellular64, colon and ovarian cancers65, 
and has also been demonstrated to promote the tumourigenicity of BCC cells66. 
Paradoxically, however, Lgr5 has also been shown to reduce the growth of colorectal cancer 
cells26,27, and tumour suppressive roles have been suggested for Lgr429 and Lgr620. 
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Germline loss of RSPO1, the upstream ligand for the Lgr family of receptors, or of LGR4, 
also causes predisposition to squamous carcinoma development in human patients28,29. We 
therefore investigated the potential role of Lgr6 as an inducer of Wnt signalling in squamous 
cells, and as a germline tumour suppressor gene.
We assessed the effects of Lgr6 deregulation on Wnt signalling in keratinocyte cell lines 
using the well characterised TOPFlash assay67. Overexpression of Lgr6 in multiple 
epidermal cell lines consistently led to activation of this pathway (Fig. 6h). Finally, analysis 
of human TCGA gene expression data on head and neck SCCs (Supplementary Tables 1 and 
2) showed a strong connection to the WNT pathway only for LGR6, and not to any 
significant extent with LGR5 or LGR4. This supports the notion that LGR6 is linked to Wnt 
signalling and may play a unique role in tumours of squamous origin.
To assess the effect of germline inactivation of Lgr6 on tumour susceptibility, we bred 
Lgr6−/− mice through multiple generations on to a pure FVB/N genetic background, and 
exposed them to the DMBA/TPA chemical carcinogenesis protocol. The knockout mice 
showed a highly significant increase in susceptibility to papilloma development (Fig. 6i), as 
well as a shortened carcinoma-free survival (Fig. 6j). We conclude that Lgr6, in spite of its 
activity as a positive stimulator of Wnt signalling, acts as a germline suppressor of SCC 
development, thus mimicking the functions of human WNT activators RSPO1 and LGR4 as 
SCC suppressor genes. One possible explanation for these apparently contradictory results is 
that germline loss of Lgr6 could cause a developmental upregulation of other pathway 
components that may compensate for loss of Lgr6 activity. Stem cells in normal skin or 
intestine display considerable plasticity, such that ablation of Lgr5 positive cells can 
stimulate their regeneration from alternative stem cell populations68. To investigate possible 
mechanisms of compensation, we derived a series of cell lines from Lgr6−/− skin SCCs, and 
analysed expression levels of the other Lgr family members. The wild type mouse 
carcinomas showed variable activation of the Wnt pathway, as demonstrated by the 
differences in levels of Phospho-β-catenin69. Of the three carcinomas tested, highest Wnt 
activity is seen in the cell line (168 cells) that also has the highest level of Lgr6 expression 
(left panel, Fig. 6k). Variable levels of Wnt activity are also seen in the carcinomas from 
Lgr6 knockout mice (right panel, Fig. 6k, Supp. Fig. 11), but in 3 of 4 cases with high 
activity, the level of Lgr5 expression is strongly upregulated (arrows). This is particularly 
significant as all of our expression data show that in SCCs from wild type mice, Lgr5 is 
switched off even at the single cell level and plays no significant role as an epithelial cancer 
stem cell marker. These data therefore identify a mechanism by which cancer stem cells in 
Lgr6−/− mice can be regenerated through a feedback mechanism resulting in upregulation of 
Lgr5.
Discussion
Using a combination of gene expression analysis, lineage tracing, single molecule in situ 
hybridisation, and PACS analysis of single tumour cells we have shown that Lgr6 satisfies 
many of the criteria of an SCC stem cell marker. Lineage tracing identified a subpopulation 
of Lgr6+ tumour cells that give rise to progressively growing epithelial clones. Lgr6 was 
enriched in aldefluor-positive cells with stem cell properties, and its inhibition resulted in 
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increased proliferation and lineage tracing in the epidermis. Although Lgr5 was not 
significantly associated with squamous tumour development or progression, it was expressed 
in rare single cells in a BCC cell line66, some of which were triple positive for all 3 Lgr 
family members. The detection of these triple positive cells in vivo in basal keratinocyte 
cells, as well as in primary carcinomas, suggests that they may have a distinct role in stem 
cell homeostasis, but this question will require further investigation.
We believe the model that best explains our results is shown in Supp. Fig. 10. In this model, 
an early stem cell population may express Lgr5 and Lgr6 as well as Lgr4, with the initial 
cell fate choice being determined by competitive interactions of these GPCRs with their R-
spondin ligands and other potential effector molecules such as Rnf4370 and Znrf371. Lgr5 
expression is maintained in some cells that can give rise to BCCs, but lost in cells that 
commit to the epidermal cell fate. In this stem cell compartment, Lgr6 functions as a brake 
towards further epidermal commitment and differentiation, such that loss of Lgr6 leads to 
increased epidermal lineage differentiation and proliferation. It is possible that loss of Lgr6 
expression (but continued expression of Lgr4) may be linked to commitment to a more 
differentiated keratinocyte state. Indeed, the highest levels of Lgr4 expression are seen in 
cell lines with the most “epithelial” characteristics such as the immortalised keratinocytes 
C5N and NK, or the differentiated papilloma cell lines MscP1 or Mscp5 (Supp. Fig. 7).
Germline deletion of Lgr6 in the mouse caused predisposition to SCC development, as also 
seen in human patients with germline loss of LGR429 or RSPO128. Tumours that arose in 
Lgr6−/− mice in fact showed upregulation of Lgr5, particularly in those tumours with the 
highest levels of Wnt signalling. These data highlight the plasticity and complex control of 
Wnt/B-catenin signalling in the skin, where activation of the pathway can maintain hair 
follicle72–74 and epidermal75 stem cell growth, but impairment in hair follicle stem cells 
stimulates commitment to the epidermal lineage73,76–78. Elevated expression of β-catenin is 
negatively associated with normal epidermal proliferation, but its localisation in the nucleus 
is positively associated with growth of Hras-transformed cells79. Successful targeting of the 
Wnt pathway for SCC therapy will require resolution of the complex mechanisms that 
distinguish signalling in these different biological contexts.
Materials and Methods
Mouse treatments, chemical carcinogenesis and lineage tracing in skin
Lgr6 KD mice were generated in a similar fashion to previously reported doxycycline- 
inducible knockdown mice80, using the Lgr6 shRNA sequence 
GCATGACACTGGAAGACAACT. Recombinant ES cells were injected into blastocysts 
and chimeric animals were obtained at the UCSF Cancer Center Transgenic and Targeted 
Mutagenesis Core Facility. Doxycycline water was prepared by dissolving 2 g of 
doxycycyline (RPI) in 1 l of water containing 50 g of sucrose (Affymetrix). For BrdU 
studies, mice were injected intraperitoneally with BrdU labelling reagent (Life 
Technologies) at a concentration of 10 µL/g of body weight and sacrificed 3 hours post- 
injection. For chemical carcinogenesis experiments, 8- to 12-week-old male and female 
mice were randomly assigned to control or treatment groups. Initiation was carried out using 
a single dose of DMBA (25 ug per mouse in acetone) applied to back skin. One week later, 
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the mice were administered biweekly topical treatments of TPA (200 uL of a 10-4 M 
solution in acetone) for 20 weeks. The animals were then monitored for papilloma number 
and progression to carcinoma. Mice were sacrificed when their first carcinoma reached 1–
1.5 cm in diameter. For fluorescent Lgr5/6GFP-Tomato lineage tracing experiments, 
papillomas were established following the chemical carcinogenesis protocol. After 8 weeks 
of TPA treatment, one topical dose of Tamoxifen (200 ul of 25 mg/ml in 100% ethanol) was 
administered to shaved back skin and papillomas were then surgically removed 2 days, 3 
weeks and 6 weeks after the initial Tamoxifen treatment for analysis. Similar lineage tracing 
was carried out with mice bearing carcinomas that arose after 24–30 weeks post initiation 
with DMBA. To preserve Lgr5/6GFP & Tomato reporter expression, prior to embedding, 
excised tumours were briefly fixed in 4% paraformaldehyde for 2 hours and then placed in 
30% sucrose overnight at 4 °C before freezing in OCT for subsequent cryosectioning. For 
Lgr6 knockdown lineage tracing experiments, 8- to 10-week-old Lgr6 KD+/−/Lgr6-EGFP-
IRES-CreERT2+/−/R26RLacZ+/− mice were administered either doxycycline water or 
vehicle for 10 days, and then given one topical dose of 4OHT (1 mg in 200 µl of 100% 
ethanol) (Sigma-Aldrich) on back skin to induce Cre expression. Mice were sacrificed in 
triplicates 7 days after induction. Animals were housed in standard conditions, fed ad 
libitum and treated in accordance with the rules and protocols stipulated by the UCSF 
Institutional Animal Care and Use Committee (IACUC). All mouse experiments were 
approved by the University of California at San Francisco Laboratory Animal Resource 
Center. Age-matched animals of the required genotypes were randomly assigned to 
treatment groups (for instance, wounded or unwounded, Supp. Fig. 2; vehicle- or dox-
treated, Fig. 6c–g). When assessing experimental outcomes in animal samples (for instance, 
BrdU staining in Fig. 6c; X-Gal staining in Fig. 6d–g), investigator was blinded through the 
use of unique animal IDs for the samples that do not indicate treatment conditions.
X-Gal staining
Back skin samples were surgically removed from 4OHT- or vehicle-treated mice and cut into 
small pieces. These were added to 4% formaldehyde diluted in PBS, and placed on a shaker 
at room temperature for 10 min. After 3 washes with PBS, the skin samples were incubated 
in X-Gal staining solution (1 mg/ml X-Gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, and 2 
mM MgCl2 in PBS) at 37 °C in the dark. The next day, the samples were washed with PBS, 
transferred to 70% ethanol and made into paraffin blocks. 6 µm sections were cut on a 
microtome and finally counterstained with nuclear fast red (Vector Laboratories).
Multiplex in situ hybridisation
ViewRNA ISH Cell Assay probes for murine Lgr4-6 were obtained from Panomics and in 
situ hybridisation was performed, according to the manufacturer’s protocol, on cells grown 
in poly-lysine coated, glass-bottom 96-well plates (In Vitro Scientific). Images were 
acquired on the 6D high throughput microscope in the UCSF Nikon Imaging Center and 
analysed using the NIS Elements and ImageJ software packages.
Single-cell RT-PCR analysis
Single cell analysis of Lgr4, Lgr5 and Lgr6 expression was performed using the Mission 
Bio, Inc. PACS platform55–57. Briefly, single keratinocyte suspensions of disaggregated back 
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skin, NK cells, E4 SCC cells, BCC cells or primary squamous carcinoma cells were stained 
with a calcein violet viability dye and encapsulated into microfluidic droplets. Droplets 
containing individually lysed cells were further processed with the PACS microfluidic 
workflow to enable droplet-based TaqMan RT-PCR detection of target transcripts. The 
multiplex RT-PCR reactions consisted of FAM labeled Lgr5, HEX labeled Lgr6 and Cy5 
labelled Lgr4 TaqMan probes. Thermocycling conditions were as follows: 15 min 50 °C, 
93 °C for 2 min, 35–40 cycles of 92 °C for 15 s and 60 °C for 1 min. Following 
thermocycling, the droplets were reinjected into a microfluidic device for fluorescence 
analysis using four coincident lasers (405 nm, 473 nm, 532 nm, and 640 nm, CNI lasers) to 
excite the cell viability stain and TaqMan probes. The resulting fluorescence channels 
(centered at 440 nm, 510 nm, 572 nm, and 680 nm) were separated from the lasers and each 
other with dichroic filters (Semrock) before being detected by four PMTs (Thorlabs). The 
detection was processed in real time using LabVIEW and the droplet scatter plots were 
generated using MATLAB.
Single-cells were analysed with the multiplexed TaqMan assay (7,334 back skin cells, 
14,454 NK cells, 21,596 E4 SCC cells, 16,914 BCC cells and 2,617 primary SCC cells). 
Three independent replicates were performed for each cell/sample type.
Immunofluorescence
First, deparaffinisation and antigen retrieval were performed on 6 µm back skin sections 
using the Trilogy pretreatment solution (Cell Marque). Then, the sections were incubated in 
10% donkey serum (Abcam) diluted in PBS containing 0.3% Triton X-100, at room 
temperature for 1 hour. Subsequently, the sections were incubated with primary antibody 
against BrdU (rat, Abcam) or GFP (rabbit, Santa Cruz) at 4 °C overnight. After washing 3 
times with PBS containing 0.1% Tween-20, the sections were incubated with the appropriate 
Alexa 488/555 conjugated secondary antibody (Molecular Probes) for 1 h at room 
temperature. After washing 3 times with PBS containing 0.1% Tween-20, the samples were 
finally mounted in Vectorshield hardset mounting medium with DAPI (Vector Laboratories). 
Lgr5/6GFP and Krt14 expression in primary SCC cryosections was visualised by incubation 
with anti-GFP (chicken, Abcam) and anti-Krt14 (rabbit, Covance) antibodies, respectively.
Western blot and RT-qPCR analysis
Lgr6 WT and Lgr6 KO cell lines were derived from SCC generated by DMBA/TPA 
treatment of WT FVB mice or FVB Lgr6 −/− mice67. SCC were harvested and digested in 
4mg ml-1 Collagenase A (Sigma Aldrich) at 37°C for 60 min with agitation, followed by 30 
min incubation in 0.25% trypsin-EDTA solution. Dissociated cells were then passed through 
a 40 µm filter (Greiner Bio-One) and seeded into a 10 cm dish with regular DMEM. For 
western blot analysis, cells were prepared with lysis buffer (CST) supplemented with 
protease inhibitors, 100 µM NAF and 100 µM Na3VO4. Protein lysates were run by SDS-
PAGE and transferred onto PVDF membranes (Biorad). After blocking, membranes were 
incubated overnight at 4°C with anti phospho β-catenin (#8814; CST) or anti β-actin 
(#4967; CST) antibodies. Anti Rabbit HRP-linked was used as secondary antibody (#7074; 
CST). Enhanced Chemoluminescence was used for detection. Phospho β-catenin membrane 
was stripped for 30 min at room temperature in Restore Plus Stripping buffer (Thermo 
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Fisher), re-blocked and incubated with anti β-catenin (#1247-1; Epitomics) antibody. For 
Lgr gene expression analysis, RNA was extracted from Lgr6 WT and Lgr6 KO cells with 
TRIzol reagent (Thermo Fisher) and reverse-transcribed using Quantitect RT kit (Qiagen). 
qPCR expression analyses were performed with the indicated primer sets (Table S3.) by 
using Power-Up SYBR green mastermix (Thermo Scientific, #A25742) and run on an 
AB7900HT instrument (Applied Biosystems). Relative gene expression was calculated by 
using L19 as housekeeping genes to generate ΔCt. ΔCt values from 1425-L1 Lgr6 WT cells 
were used as reference to generate ΔΔCt, and relative gene expression was calculated as 
2(−ΔΔCt), or presented as copy number/1,000 copies of L19 to calculate gene expression. All 
reactions were run in duplicate. For primer sequences, see table S3.
Cell culture treatments, MTT and TOPFlash assays
Doxycycline was administered, where appropriate, at a concentration of 1 µg/mL of culture 
medium. The shRNA sequence used to target Lgr6 in E4 cells is identical to the one used to 
generate the Lgr6 KD mice (see above) and this was cloned into the doxycycline-inducible 
F1HtUTG lentiviral vector81. For MTT assays, 2000 (Lgr6 ox and null NK) or 4000 (Lgr6 
shRNA and null E4) cells were seeded in each well of a 96-well plate and the culture 
medium was replaced every third day. The Vybrant MTT Cell Proliferation Assay (Life 
Technologies) was performed according to the manufacturer’s protocol at the indicated time 
points after initial seeding. For TOPFlash assays, cells grown in 6-well plates were first 
transfected with 2 µg of the M50 Super 8x TOPFlash plasmid and 0.1 µg of the pRL-TK 
renilla luciferase plasmid per well, using Lipofectamine 2000 (Invitrogen). After 6 hours, 
the medium was replaced and doxycycline was added, where appropriate. 2 days later, 
luciferase activity was determined for each well using the Dual-Luciferase Reporter Assay 
System (Promega) with the GloMax Luminometer, according to the manufacturer’s 
instructions.
Cell Lines and Microarray analysis
The cell lines shown in Supplementary Figure 7 were described previously55,51,82,83 (and 
references therein). NK cells and C5 cells are immortalised keratinocytes derived from wild 
type (C5) or Trp53 null mice (NK). Hras null cells were derived from a carcinoma induced 
by DMBA/TPA in Hras knockout mice57. All of the other lines carry initiating mutations in 
the Hras gene. Cells were grown in serum supplemented media into the log phase, then 
TRIzol RNA extraction was then performed, followed by purification by Qiagen kit. Gene 
expression analysis of RNA samples from these lines was carried out using Affymetrix 
M430 2.0 arrays. Microarray CEL files were background corrected and normalised with 
RMA using oligo in R and then log2 transformed prior to analysis. Cell lines were routinely 
tested for mycoplasma contamination.
Data Availability
The cell line gene expression microarray data have been deposited in GEO at the time of 
submission with accession number GSE88742
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Aldefluor, colony formation assays and qPCR
Cells cultured in vitro were trypsinised and stained with Aldefluor (and DEAB) (Stem Cell 
Technologies), according to the manufacturer’s instructions. The cells were then sorted into 
Aldefluor+ and Aldefluor− fractions on the BD FACSAria III. For expression analyses, RNA 
was extracted from the sorted cells using TRIzol (Invitrogen), and reverse transcription was 
performed using the High Capacity Reverse Transcription Kit (Life Technologies). qPCR 
reactions were subsequently run on the AB7900HT, using Taqman gene expression assays 
for Lgr4 (ID Mm00554385_m1), Lgr5 (ID Mm00438890_m1 and Mm01251804_m1) and 
Lgr6 (ID Mm01291336_m1) (Life Technologies). Within each sample, the Ct value for beta-
actin was used as a reference to calculate delta Ct values for genes of interest. For each 
qPCR experiment, all samples were run in technical triplicates and the mean delta Ct value 
amongst the technical triplicates was determined for genes of interest; all samples were 
further run in biological triplicates and the data presented show the mean and s.e. amongst 
these biological triplicates.
For colony formation assays, 2000 cells were seeded in each well of a 6-well plate and 
grown in a 37 °C cell culture incubator for 19 days. The cells were then fixed in ice-cold 
methanol for 10 min and finally stained with crystal violet for 10 min.
Statistical analysis
Statistical analyses were carried out using the Prism software package (Graphpad). 
Significance of difference between two groups was determined using the unpaired, two-
tailed Student’s t test and labelled as follows: * for p < 0.05; ** for p < 0.01; and *** for p < 
0.001. F-tests indicate no evidence of a statistically significant difference in variances of all 
groups being compared, except in Fig. 5d, 5g (null samples), 6c, 6e and 6h (H11 samples), 
where Welch’s correction is applied. Significance analysis for multiple groups was analysed 
by ANOVA.
As we could not anticipate an effect size prior to performing our initial experiments, rather 
than performing a power calculation we defined cohort size by estimating from prior work. 
We evaluated our prior experimental evidence from unrelated experiments to define a size 
that allowed us to detect a both statistically as well as practically meaningful difference 
between the genotypes. In our experiments, using the two-stage carcinogenesis protocol, this 
is generally between 10 and 20 mice, assuming a less than 5% dropout rate during 
carcinogenesis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Lgr6 expression increases with squamous tumour progression and Lgr6GFP+ cells, not 
Lgr5GFP+ cells, are localised within tumour epithelium
Levels of Lgr5 and Lgr6 expression during tumour progression were analysed in samples of 
normal skin, papillomas, primary carcinomas and matched metastatic tumours from an 
interspecific FVBBX backcross population. (a) Lgr6 expression continues to rise through 
benign, malignant carcinoma and metastasis stages, while Lgr5 expression shows a 
progressive decrease. Localised expression of Lgr5GFP and Lgr6GFP was investigated 
within primary squamous carcinomas (at 25wks after initial TPA treatment) by 
immunostaining against GFP (green) or Keratin 14 (Krt14, red) to identify cell populations 
specifically expressing stem cell or basal cell markers. (b−e) Representative sections from 
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squamous tumours demonstrating that Lgr6GFP (e, arrows), but not Lgr5GFP (c), is clearly 
expressed in distinct colonies of cells distributed through the SCCs. (b, d) H&E staining of 
serial sections of immunostaining depicted in (c) and (e), respectively. Yellow dotted boxes 
demarcate magnified regions of interest in (c) and (e). White dotted line indicates epithelial 
border indicated by Krt14 (red) expression. DAPI staining (blue) localises cell nuclei. Scale 
bar = 50µm.
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Figure 2. Lgr6-derived clonal expansion is observed in benign squamous tumours
Lgr5- and Lgr6-derived lineage tracing was performed within chemically induced skin 
tumours from Lgr6-EGFP-CreERT2 or Lgr5-EGFP-CreERT2 mice crossed with Rosa26-
LSL-Tomato reporter mice by standard DMBA treatment followed by 8 weeks of tumour 
promotion using TPA. Mice were then treated with Tamoxifen (TAM) and papillomas were 
harvested at 2 days, 3 weeks and 6 weeks thereafter, to measure the extent of lineage tracing 
from either Lgr5GFP- or Lgr6GFP-positive stem cells. (a) At 2 days post- TAM, no Lgr5-
derived Tomato+ cells (red) were readily observed in papilloma epithelium, however, in 
Lgr6-reporter mice, rare Lgr6GFP+Tomato+ cells were localised in the epithelial 
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compartment (b). (c, e, g) Over time, rare Lgr5-derived, Tomato+ cells (arrow) were 
observed in papilloma epithelium, in contrast, Lgr6-derived, Tomato+ traced cell numbers 
increased at 3 weeks (g) and 6 weeks, giving rise to distinct epithelial clones (d,f). Yellow 
dotted box demarcates the magnified regions in the figure insets. White dotted line indicates 
epithelial-dermal border. DAPI staining (blue) localises cell nuclei. Scale bar = 50µm.
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Figure 3. Lgr6-derived clonal expansion in primary SCCs
Lgr6-derived lineage tracing was performed within chemically induced primary (1°) SCCs 
from Lgr6-EGFP-CreERT2 mice crossed with Rosa26-LSL-Tomato reporter mice by 
standard DMBA treatment followed by 20 weeks of tumour promotion using TPA. Once 
SCCs were readily visible, mice were treated with Tamoxifen (TAM) and a biopsy was taken 
2 days later, showing abundant Lgr6GFP+Tomato+ cells (red) localised in the epithelial 
compartment (b) as well as some Lgr6GFP+ cells (green, *) lacking recombination. (c,d) In 
the same tumour 2 weeks after TAM treatment, distinct Lgr6GFP+/Tomato+ clones were 
observed (d, inset) and at 4wks post-labelling (e, f), substantial Tomato+ cell labelling was 
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observed within the epithelial tumour tissue. Yellow dotted box demarcates the magnified 
regions in the figure insets. White line indicates epithelial-dermal border. DAPI (blue) 
staining was used to visualise cell nuclei. (a) H&E sections of images depicted in (b) to 
provide tumour histology. Scale bar = 50µm.
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Figure 4. Lgr5 is expressed in rare single BCC cells but not in SCC cells / Lgr6, and not Lgr5, is 
an SCC CSC marker
(a) Taqman analysis showing the expression of Lgr4-6 in a panel of BCC (Asz001), 
immortalised keratinocyte (C5N, NK), papilloma (P6), SCC (B9-2, E4) and spindle 
carcinoma (D3, H11, CarB) cell lines, and control normal back skin samples. Data are 
presented as mean ± s.e. n = 3. Arrow indicates Lgr5 expression in Asz001. (b) rt-PCR 
analysis showing the expression of Lgr4-6 in RNA extracted from a Asz001 sample (above) 
and a NK sample (below). Lgr4-6 multiplex in situ hybridisation was performed in Asz001 
BCC cells. Repeat rt-PCR using biological replicates of Asz001 and NK samples shows the 
same results. (c), immortalised keratinocytes (C5N) (d) and E4 SCC cells (e). The Lgr4 
(purple) expression pattern is shown in the left panel, while both Lgr5 (green) and Lgr6 (red) 
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expression patterns are shown in the right panels. Yellow asterisks point to cells of interest in 
each cell line. (f) PCR-activated cell sorting (PACS) analysis of Lgr4-6 expression in dorsal 
back skin, NK cells, E4 SCC cells and Asz001 BCC cells, n=3. Scale bar = 50 µm.
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Figure 5. Lgr6 is enriched in epidermal cells with stem cell properties and has growth inhibitory 
effects in epidermal cell lines
(a,b) Putative stem cell subpopulations were isolated from immortalised keratinocytes 
(C5N) (a) and SCC cells (D3) (b) based on enrichment for Aldefluor activity. Lgr6 
expression level was determined in the sorted Aldefluor+ and Aldefluor− populations using 
Taqman analysis. (c) Normal epidermal cells (C5N) were sorted into Aldefluor− and 
Aldefluor+ subpopulations and these were separately seeded at low density (2000 cells per 
well) in 6-well plates. Colonies were allowed to grow for 19 days before being visualised by 
staining with crystal violet. (c) Representative wells showing colony formation by 
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Aldefluor− cells (left) and Aldefluor+ cells (right). For each well, the colonies were 
manually counted and the cell area was calculated in ImageJ to determine the colony 
formation efficiency and average colony area (c). Data are presented as mean ± s.e. *p < 
0.05, **p < 0.01 and ***p < 0.001. n = 5 for (a) and (b), and n = 3 for (c). (d,e) 
Immortalised keratinocytes (NK) were transduced with an inducible Lgr6 expression 
construct (Lgr6 ox cells) or left unmodified (null cells). The cells were then grown either in 
the presence of absence of doxycycline, and growth was monitored at various timepoints 
using the MTT assay. (d) Taqman analysis showing Lgr4-6 mRNA levels in Lgr6 ox NK 
cells after 3 days of growth in the presence or absence of doxycycline. (e) Growth curves of 
Lgr6 ox or null NK cells cultured in the presence or absence of doxycycline. (f,g) SCC cells 
(E4) were transduced with an inducible Lgr6 shRNA construct (Lgr6 shRNA cells) or left 
unmodified (null cells). The cells were then grown either in the presence or absence of 
doxycycline, and growth was monitored at various timepoints using the MTT assay. (f) 
Taqman analysis showing Lgr4-6 mRNA levels in Lgr6 shRNA E4 cells after 3 days of 
growth in the presence or absence of doxycycline. (g) Growth curves of Lgr6 shRNA or null 
E4 cells cultured in the presence or absence of doxycycline. Data are presented as mean ± 
s.e. ***p < 0.001 and **p < 0.01. n = 3 for (d) and (f), and n = 5 for (e) and (g).
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Figure 6. Lgr6 deficiency increases proliferation in the epidermis and leads to expanded Lgr6 
lineage tracing into the epidermis
Adult Lgr6 KD+/− mice were administered doxycycline water or vehicle for 10 days. The 
animals were then intraperitoneally injected with BrdU and skin samples were harvested 3 h 
later. (a) Cartoon depicting mechanism of Lgr6 knockdown induced by doxycycline 
treatment of Lgr6 KD+/− mice. In the absence of doxycycline, the tet repressor sits on the 
H1-tetO promoter80 and prevents the transcription of the Lgr6 shRNA. In the presence of 
doxycycline, the tet repressor is bound by the drug and prevented from associating with the 
H1-tetO promoter; this in turn allows for the transcription of the Lgr6 shRNA. (b) Lgr4-6 
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mRNA levels in back skin samples were determined through Taqman analysis. (c) Top, 
example sections showing anti-BrdU immunofluorescence staining in back skin of Lgr6 
KD+/− mice administered either vehicle (left) or doxycycline water (right). White 
arrowheads point to BrdU+ cells. Quantitation of anti-BrdU staining in vehicle- or 
doxycycline-treated Lgr6 KD+/− mice was also performed with 20 different fields of skin 
sections examined for each mouse. n ≥ 5 mice in each treatment group for (b) and (c). (d) 
Adult Lgr6 KD+/−/Lgr6-EGFP-IRES-CreERT2+/−/R26RLacZ+/− mice were administered 
either doxycycline water or vehicle. 10 days later, lineage tracing was induced with a topical 
dose of 4OHT; 7 days thereafter, skin samples were harvested and stained with X-Gal. (d) 
Representative sections showing X-Gal staining of skins from vehicle-treated (left) or 
doxycycline-treated (right) mice, n = 3 mice in each treatment group. (e-g) 20 different 
fields of skin sections were examined for each mouse to determine the number of traced 
cells per unit epidermal length (e), the number of Lgr6 clones per unit epidermal length (f) 
and the clone size distribution (g). Values lying further than 1.5 times the interquartile range 
in the box-and-whisker plots are plotted as dots. (h) A panel of normal and transformed 
epidermal cell lines was first transduced with an Lgr6 expression construct. Then, Lgr6 
expression in these cells was either induced or left unperturbed through administering 
doxycycline or vehicle, respectively. After 2 days, Wnt activity was assessed using the 
TOPFlash luciferase reporter assay. n = 3. Adult Lgr6+/+ and Lgr6−/− mice were initiated 
with a single dose of DMBA, then biweekly treatments of TPA for 20 weeks. (i) Papilloma 
burden by Lgr6 genotype. Box-and-whisker plot depicting papilloma burden at 2 week 
intervals from week 10 to week 20 during DMBA/TPA mediated carcinogenesis. Mice are 
grouped and coloured by Lgr6 genotype. The Lgr6+/+ group consisted of 19 mice, and the 
Lgr6−/− group of 13 mice. Values lying further than 1.5 times the interquartile range are 
plotted as dots. Genotype is significantly associated with papilloma burden across all 
timepoints (p < 0.05 by ANOVA). (j) Carcinoma-free survival by Lgr6 genotype. Kaplan-
Meier plot for carcinoma-free survival in Lgr6 WT and KO mice (p < 0.05 by log-rank test). 
The Lgr6+/+ group consisted of 15 mice, and the Lgr6−/− group of 13 mice. Both cohorts 
consisted of approximately equal numbers of male and female mice. (k) Reactivation of 
Lgr5 expression and Wnt signalling in SCCs from Lgr6 knockout mice. The left panel shows 
heterogeneous activation of the Wnt pathway (denoted by a low level of the Phospho β-
catenin) in tumours from wild type mice. The SCC with the highest level of Lgr6 expression 
(168 cells) has the strongest activation of the Wnt pathway. There is no expression of Lgr5 
in SCCs from wild type mice. The right panel shows a series of 9 cell lines derived from 
Lgr6 knockout mice, of which 5 have strong activation of Wnt signalling. Four of these 
(denoted by the red arrows) have both low levels of Phospho-β-catenin and high levels of 
Lgr5.
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